HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor markers and 18F-FDG PET/CT after orchiectomy in seminoma: Is there any correlation?

AbstractOBJECTIVE:
The aim of our study was to analyze the potential relationship between tumor markers and 18F-fluorodoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) results in patients affected by seminoma.
MATERIAL AND METHODS:
65 18F-FDG PET/CT scans of 41 patients with diagnosis of seminoma were analyzed and compared to alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG). PET/CT studies were analyzed qualitatively and measuring the maximum and mean standardized uptake value body weight max (SUVbwmax, SUVbwmean), maximum SUV lean body mass (SUVlbm), maximum SUV body surface area (SUVbsa), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of hypermetabolic lesions. All values were compared with serum markers.
RESULTS:
31 PET/CT studies were true negative, 28 true positive, 6 false positive and 0 false negative with sensitivity of 100%, specificity of 84%, negative predictive value of 100%, positive predictive value of 82% and accuracy of 91%. No correlation between PET results and tumor marker levels was found and also between AFP and PET/CT semiquantitive parameters. All semiquantitative PET parameters were significantly related to hCG level.
CONCLUSIONS:
18F-FDG PET/CT has good accuracy in evaluating patients with relapsed seminoma. HCG levels were significantly correlated with metabolic PET/CT parameters.
AuthorsFrancesco Dondi, Domenico Albano, Francesco Bertagna, Raffaele Giubbini
JournalRevista espanola de medicina nuclear e imagen molecular (Rev Esp Med Nucl Imagen Mol (Engl Ed)) 2021 Sep-Oct Vol. 40 Issue 5 Pg. 287-292 ISSN: 2253-8089 [Electronic] Spain
PMID34425969 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • Chorionic Gonadotropin
  • Radiopharmaceuticals
  • alpha-Fetoproteins
  • Fluorodeoxyglucose F18
Topics
  • Adult
  • Biomarkers, Tumor (blood)
  • Chorionic Gonadotropin (blood)
  • Fluorodeoxyglucose F18
  • Glycolysis
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (blood, diagnostic imaging)
  • Orchiectomy
  • Positron Emission Tomography Computed Tomography
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Retrospective Studies
  • Seminoma (blood, diagnostic imaging, pathology, surgery)
  • Testicular Neoplasms (blood, diagnostic imaging, pathology, surgery)
  • Tumor Burden
  • Young Adult
  • alpha-Fetoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: